Pilocarpine
From Wikipedia, the free encyclopedia
 |
|
|
Pilocarpine
|
|
| Systematic (IUPAC) name | |
| (3S,4R)-3-ethyl-4-((1-methyl-1H-imidazol-5-yl) methyl)dihydrofuran-2(3H)-one | |
| Identifiers | |
| CAS number | 54-71-7 |
| ATC code | N07 S01EB01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C11H16N2O2 |
| Mol. mass | 208.257 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 0.76 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pilocarpine is a muscarinic alkaloid obtained from the leaves of tropical American shrubs from the genus Pilocarpus. It is a non-selective muscarinic receptor agonist[1] in the parasympathetic nervous system, which acts therapeutically at the muscarinic acetylcholine receptor M3 due to its topical application[2], e.g. in glaucoma and xerostomia.
Contents |
[edit] Clinical uses
Pilocarpine has been used in the treatment of chronic open-angle glaucoma and acute angle-closure glaucoma for over 100 years[1]. It acts on a subtype of muscarinic receptor (M3) found on the iris sphincter muscle, causing the muscle to contract and produce miosis. This opens the trabecular meshwork through increased tension on the scleral spur. This action facilitates the rate that aqueous humor leaves the eye to decrease intraocular pressure.
In ophthalmology pilocarpine is also used to reduce the possibility of glare at night from lights if the patient underwent implantation of phakic intraocular lenses; the use of pilocarpine would reduce the size of the pupils, relieving these symptoms. The most common concentration for this use is pilocarpine 1%, the weakest concentration.
Pilocarpine is also used to treat dry mouth (xerostomia), e.g. as a side effect of radiation therapy for head and neck cancers. Pilocarpine stimulates the secretion of large amounts of saliva and sweat.
Pilocarpine is used to stimulate sweat glands in a sweat test to measure the concentration of chloride and sodium that is excreted in sweat. It is used to diagnose cystic fibrosis (CF).
[edit] Trade names
Pilocarpine is available under several trade names such as: Diocarpine (Dioptic), Isopto Carpine (Alcon), Miocarpine (CIBA Vision), Ocusert Pilo-20 and -40 (Alza), Pilopine HS (Alcon), Salagen (MGI Pharma), Scheinpharm Pilocarpine (Schein Pharmaceutical), and Timpilo (Merck Frosst).
[edit] Adverse effects
Use of pilocarpine may result in a range of adverse effects, most of them related to its non-selective action as a muscarinic receptor agonist. Pilocarpine has been known to cause excessive sweating, excessive salivation, bronchospasm, increased bronchial mucus secretion, bradycardia, hypotension, browache (when used as eye drops) and diarrhea. It can also result in miosis when used chronically as an eye drop.
The therapeutic uses of pilocarpine are limited by its adverse effects.
[edit] Sources
- Katzung, Bertram. Basic and Clinical Pharmacology, 9th ed. (2004). ISBN 0-07-141092-9
- Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
- Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4
|
|||||||||||
|
||||||||||||||||||||
[edit] References
- ^ Spalding et al 2002
- ^ Pharmacology, (Rang, Dale, Ritter & Moore, ISBN 0443071454, 5:th ed., Churchill Livingstone 2003) Page 144
